MMSET-IN-1 |
| Catalog No.GC36636 |
MMSET-IN-1 est un inhibiteur du domaine SET du myélome multiple (MMSET, alias NSD2/WHSC1) contre SETD2 et MMSET avec des IC50 de 0,49 et 3,3 μM, respectivement. MMSET-IN-1 a un Kd de 1,6 μM pour MMSET.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1998139-29-9
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
MMSET-IN-1 is a multiple myeloma SET domain (MMSET, aka NSD2/WHSC1) inhibitor against SETD2 and MMSET with IC50s of 0.49 and 3.3 μM, respectively. MMSET-IN-1 has a Kd of 1.6 μM for MMSET[1]. IC50: 0.49 μM (SETD2), 3.3 μM (MMSET)[1]Kd: 1.6 μM[1]
[1]. Tisi D, et al. Structure of the Epigenetic Oncogene MMSET and Inhibition by N-Alkyl Sinefungin Derivatives. ACS Chem Biol. 2016 Nov 18;11(11):3093-3105.
Average Rating: 5 (Based on Reviews and 19 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *